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Growing evidence has shown the promise of mesenchymal stromal cells (MSCs) for
the treatment of cutaneous wound healing. We have previously demonstrated that
MSCs seeded on an artificial dermal matrix, Integra (Integra Lifesciences Corp.,
Plainsboro, NJ) enriched with platelet-rich plasma (Ematrix) have enhanced prolif-
erative potential in vitro as compared with those cultured on the scaffold alone. In this
study, we extended the experimentation by evaluating the efficacy of the MSCs
seeded scaffolds in the healing of skin wounds in an animal model in vivo. It was
found that the presence of MSCs within the scaffolds greatly ameliorated the quality
of regenerated skin, reduced collagen deposition, enhanced reepithelization,
increased neo-angiogenesis, and promoted a greater return of hair follicles and
sebaceous glands. The mechanisms involved in these beneficial effects were likely
related to the ability of MSCs to release paracrine factors modulating the wound
healing response. MSC-seeded scaffolds, in fact, up-regulated matrix metallopro-
teinase 9 expression in the extracellular matrix and enhanced the recruitment of
endogenous progenitors during tissue repair. In conclusion, the results of this study
provide evidence that the treatment with MSC-seeded scaffolds of cutaneous wounds
contributes to the recreation of a suitable microenvironment for promoting tissue
repair/regeneration at the implantation sites.
Bone marrow-derived mesenchymal stromal cells (MSCs)
generate great expectation in the field of regenerative medi-
cine due to the easy isolation and expansion, unique anti-
inflammatory and immune-modulatory properties, and their
potential multipotency.1–4 These cells have been successfully
used in cell-based therapies for cutaneous regeneration
experiments and, recently, clinically explored for improving
burn healing and reepithelialization of chronic ulcerated
skin.5,6 However, the detailed mechanisms of the beneficial
effects of these cells are far from being clarified and must be
elucidated before MSCs could be widely transferred from the
bench to the bedside. Several recent reports suggest that dif-
ferentiation or transdifferentiation of MSCs is involved in
wound healing of skin and appendages;7–9 their differentiation
into multiple skin cell types has been confirmed by the
expression of specific epidermal markers, including
cytokeratin and filaggrin.10,11 Other researchers have, instead,
distinct opinion, suggesting that MSCs participate in skin
repair/regeneration in the absence of a significant long-term
engraftment through the secretion of paracrine factors that
stimulate survival, proliferation, migration, and differentia-
tion of the resident cells.12–16 In particular, enzyme-linked
immunosorbent assay has shown that conditioned medium
from MSCs contains a wide variety of growth factors and
cytokines, such as epidermal growth factor, fibroblast growth
factor (FGF), vascular endothelial growth factor (VEGF),
IL-6, IL-8, plus fibrinolytic enzymes and matrix metal-
loproteinases (MMPs), which may influence cellular activi-
ties in the wound microenvironment and consequently
regulate the reparative quality outcome.17–21 Indeed, VEGF
and FGF have been reported to prime neo-angiogenesis by
stimulating endothelial precursors to migrate and aggregate
into primary capillary plexus,22 and the up-regulated expres-
sion of MMPs, a family of enzymes that selectively digests
individual components of ECM, exerts an antifibrotic effect
through the inhibition of excessive collagen deposition at
wound sites.23,24 This latter effect, in turn, may permit cell
migration and the restoration of tissue continuity. On the other
hand, fibrosis of the skin represents a major symptomatic
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clinical issue because it can lead to the formation of abnormal
scar (such as hypertrophic scarring and keloids), which causes
significant problems in tissue growth, function, and
aesthetics.25–27
On these bases, most of the current research is now directed
to the identification of appropriate scaffolds with suitable bio-
mechanical properties to support MSCs’ viability and growth in
the hostile wound microenvironment and retain them at the
desired location, thus enhancing their trophic activity on the host
tissue.28,29 In this line, we have previously demonstrated the
good potential for using MSCs via tissue-engineered constructs
by showing that the combination of an artificial dermal matrix,
Integra (Integra Lifesciences Corp., Plainsboro, NJ), with
platelet-rich plasma (PRP) (Ematrix) may represent a promising
approach to optimize MSC engraftment in cutaneous wounds.30
In the present study, we wanted to test the therapeutic efficacy in
vivo of this peculiar substrate for skin regeneration. To this
purpose, MSCs isolated from green fluorescent protein (GFP)
transgenic rats were seeded on Integra matrix adsorbed or not
with PRP and then implanted into prepared wounds on the
dorsum of rats. The scaffolds without cells were implanted on
the other side of the dorsum. The results of our study contribute
to clarify the mechanisms underlying the therapeutic benefits of
MSCs for skin repair/regeneration, suggesting that these cells,
when seeded into the bioengineered scaffold Integra + PRP
(Ematrix), are able to ameliorate the quality of tissue repair and
contribute to skin regeneration through paracrine mechanisms.
MATERIALS AND METHODS
Ethics statement
All animal manipulations were carried out according to the
European Community guidelines for animal care (DL 116/92,
application of the European Communities Council Directive
of 24 November 1986; 86/609/EEC) and approved by the
Committee for Animal Care and Experimental Use of the
University of Florence. The experimental procedures were
authorized by Italian Ministry of Health (215/2012—B)
according to the Italian law (Art.7/D.lgs 116/92). The animals
were housed with free access to food and water and main-
tained on a 12-hour light/dark cycle at 22 °C room tempera-
ture (RT). All efforts were made to minimize the animal
suffering and the number of animals sacrificed.
Experimental animals
Eighteen male Lewis rats (8-week old) (Harlan Laboratories,
Correzzana-Monza, Italy), weighing 250 ± 20 g, were anes-
thetized with 4% chloral hydrate (40 mg/Kg) via intraperito-
neal injection. After having shaved and cleaned with
chlorexidine 2%, two rectangles (one for each side, 2 × 4 cm)
were outlined with a permanent marker on the dorsum of the
rats. The incisions were made along the marked edges reach-
ing the subcutaneous layer, and the overlying skin was
excised. The animals were randomly divided into three groups
of six animals each:
• Control animals, undergoing surgery and left to heal
spontaneously;
• Animals treated with Integra matrix (2 × 4 cm) on the
left side and Integra matrix (2 × 4 cm) seeded with rat
GFP-labeled MSCs (1 × 106 cells) on the right side; and
• Animals treated with Ematrix (2 × 4 cm adsorbed with
1.2 mL of PRP) on the left side and Ematrix seeded with
rat GFP-labeled MSC (2 × 4 cm adsorbed with 1.2 mL of
PRP + 1 × 106 cells) on the right side.
Integra matrix and Ematrix were fixed to the skin using 5-0
Monocryl surgical suture (Ethicon Inc., Somerville, NJ). The
wounds were then covered with a gauze containing silver salts
(Acticoat, Smith & Nephew, Hull, United Kingdom) and then
wrapped with a sterile bandage. At the end of the surgical
treatment, the rats received an intramuscular dose of antibi-
otics (gentamycin sulphate, Italfarmaco, Milan, Italy; and
amoxicillin clavulanic acid, Sandoz, Varese, Italy) and a fen-
tanyl patch for pain relief for 5 days. To minimize possible
risks of rejection due to the use of different species material
(bovine collagen, human PRP), the animals received
cyclosporine A 0.5 mg/kg (Sandimunn, Sandoz) the day
before and during 5 days after surgery.
Cell isolation
Transgenic bone marrow GFP-labeled MSCs were isolated
from male GFP transgenic Lewis rats (RRRC, Columbia,
MO), expanded and characterized as described previously.17
GFP-labeled MSCs were analyzed for green fluorescence
intensity at different passages in culture as well as for the
expression of particular cell surface molecules using flow
cytometry procedures: CD45-CyChromeTM, CD11b-FITC
(in order to quantify hematopoietic-monocytic contamina-
tion), CD90-PE, CD73-PE, CD44-PE (BD Pharmingen, San
Diego, CA).
Matrices
Integra (INTEGRA Bilayer Matrix Wound Dressing; Integra
Lifesciences Corp.) is a bilayer membrane system used as a
dermal regeneration template for skin replacement. It consists
of a dermal layer made up of a porous matrix of bovine tendon
collagen (92%) and chondroitin-6-sulfate (8%) with a mean
pore diameter ranging from 30 to 120 μm and a global poros-
ity of 98%. The epidermal substitute layer is made up of
synthetic polysiloxane polymer. In some experiments, Integra
was adsorbed with PRP to obtain a recently patented
bioengineered scaffold, Ematrix, 3 hours before experiments.
Ematrix, is a patent belonging to AOUC Careggi Hospital
(FI2008A000070), invented by C. Mirabella. PRP was
obtained by plateletpheresis from the whole blood of adult
healthy volunteers after receiving an informed consent and
centrifuged at 2,012 g for 10 minutes; the platelets were next
leucodepleted, irradiated, and counted automatically using a
hematology analyzer. PRP was activated with a solution of
thrombin and calcium chloride (1 : 10) and then dropped on
the dermal layer of Integra matrix stirred and left until gel
formation; the final platelet concentration within the matrix
was of 1.2 × 106/μL of PRP.30
Cell seeding
Rat GFP-labeled MSCs were grown in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 20% fetal bovine
serum, 2-mM L-glutamine, 100 U/mL penicillin/streptomycin
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(Sigma, Milan, Italy) at 37 °C in a humidified atmosphere of 5%
CO2. Subconfluent cells were washed with PBS twice, detached
with trypsin/EDTA, counted, and expanded in plastic adherence
before being used for the experiments on Integra and Ematrix.
In order to obtain a homogeneous population avoiding hemato-
poietic contamination, cells at passage P4-P5 were used for all
of the experiments. Rat GFP-labeled MSCs (1 × 106 cells) were
dropped on the dermal layers of scaffolds 24 hours before the
surgical treatment. Unseeded matrices (Integra and Ematrix)
were used as control matrices.
Morphological analysis
Wound punch biopsies (2 × 4 mm) were obtained from the
anesthetized rats after 7, 14, and 28 days from wounding.
Bioptic fragments were taken after removing the polysiloxane
layer and allowing a 2-mm border of implanted scaffold to be
left around the edge of the wound. The specimens were, then,
fixed in 10% buffered formalin, dehydrated in alcohol,
cleared in xylene, and embedded in paraffin. Sections 8 μm
thick were stained with hematoxylin and eosin and observed
under a light microscope. Parallel samples were fixed in 4%
paraformaldehyde in PBS overnight, then transferred to PBS
containing 30% sucrose and finally frozen at −80 °C. Cryostat
sections, 10 μm thick, were permeabilized with cold acetone
for 10 minutes, blocked with a solution containing 0.5%
bovine serum albumin (Sigma) and 0.2% gelatin in PBS for
30 minutes, and then incubated at 4 °C overnight with the
following antibodies: mouse monoclonal anti-GFP rhodamine
(1 : 200; Santa Cruz Biotechnology, Heidelberg, Germany),
mouse monoclonal anti-pan-cytokeratin (1.50; Leica
Biosystems, Milan, Italy), rabbit polyclonal anti-Ki67
(1 : 100; Abcam, Cambridge, UK), mouse monoclonal anti
CD31 (1 : 50; Dako, Milan, Italy), rabbit polyclonal anti-
MMP2 (1 : 200; Abcam), and rabbit polyclonal anti- matrix
metalloproteinase 9 (MMP9; 1 : 100; Abcam). The
immunoreactions were revealed by incubation with specific
anti-mouse Alexa Fluor 488-conjugated IgG, anti-rabbit
Alexa Fluor 488-conjugated IgG, or anti-rabbit Alexa Fluor
568-conjugated IgG (1 : 200; Molecular Probes Inc., Eugene,
OR) for 1 hour at RT. In some experiments, counterstaining
was performed with Syto16 (1 : 1,000; Molecular Probes
Inc.) to reveal nuclei. After washing in PBS, the sections were
mounted with an antifade mounting medium (Biomeda Gel
mount, Electron Microscopy Sciences, Foster City, CA). A
negative control was performed by replacing the primary anti-
body with nonimmune mouse serum. Sections were examined
with a Leica TCS SP5 confocal laser scanning microscope
(Leica Microsystem, Mannheim, Germany) equipped with a
HeNe/Argon laser source for fluorescence measurements.
Fluorescence was collected using a Leica PlanApo X63 oil-
immersion objective. Optical sections (1,024 × 1,024 pixels;
Leica Microsystem) at intervals of 0.8 μm were obtained and
superimposed to create a single composite image.
When needed, a single optical fluorescent section and DIC
images were merged to better define the localization of immu-
nofluorescent signals. The mean number of MSCs was
counted in 10 optical field (35,000 μm2) per section (three per
group) from biopsies of animals treated with MSC-seeded
Integra and Ematrix.
Quantification of pan-cytokeratin and Ki67+ cells, CD31+
blood vessels, and densitometric analysis of the intensity of
MMP2 and MMP9 fluorescent signal was performed on digi-
tized images using ImageJ software (http://imagej.nih.gov/ij/)
in 20 regions of interest of 100 μm2 for each confocal stack (at
least 10). The number of CD31-positive microvessels in the
dermal layer was also quantified in 10 optical field
(13,000 μm2) per section (three per group) from biopsies of
each group of animals.
The evaluation of tissue fibrosis was carried out on cryostat
sections (10 μm thick) fixed in paraformaldehyde vapors and
stained with Van Gieson method for collagen.31 The subepi-
dermal collagen deposition was calculated as percentage of
area covered by collagen out of the total subepidermal area.
The mean epithelial thickness as well as the number of hair
follicles was evaluated in 10 optical field (2.16 mm2) per
section (three per group) from biopsies of each group of
animals.
Clinical evaluation
All the animals were monitored daily for weight and matrix
conditions to exclude possible infection or loss of matrix.
Statistical analysis
Each experiment was performed in triplicate, and the data
obtained were reported as mean ± SEM; statistical signifi-
cance was determined by Student’s t test or one-way anova
and Newman–Keuls multiple comparison test (if more than
two groups were compared). A p value < 0.05 was considered
as significant. Calculations were performed using GraphPad
Prism software (GraphPad, San Diego, CA).
RESULTS
Clinical examination revealed that the full-thickness wounds
treated with MSC-seeded Integra and Ematrix showed accel-
erated healing as compared with the untreated, Integra and
Ematrix-treated groups. In particular, in the animals treated
with the MSC-seeded matrices, the wounds appeared com-
pletely reepithelialized and showed an evident return of hair
follicles (see Figure 1C). Confocal microscopic evaluation
showed that both the unseeded and MSC-seeded scaffolds
(Integra and Ematrix) were fully integrated into the host skin
since the early times (7–14 days) postwounding, as judged by
their complete colonization by rat tissues (Figure 2). Giant
histiocytes (foreign body reaction) were sometimes observed
within the pores of the seeded matrices at both 7 and 14 days
postwounding (data not shown).
To determine the persistence of MSCs within the pores of
the engrafted matrices, we analyzed wounds for MSC content
using GFP as a cell marker. It was found that the amount of
GFP+ cells within the Ematrix was significantly higher as
compared with that of Integra (Figure 2), consistent with our
previous observations that Ematrix provides a better microen-
vironment to suit the need and influence MSC functions.30 In
both the experimental conditions, the cells were found inter-
mingled with the surrounding host cells (Figure 2).
We also showed that wounds in the animals treated
with MSC-seeded Integra and Ematrix matured faster than
wounds in untreated or Integra and Ematrix-treated animals.
In particular, the healing process was characterized by an
initial inflammatory phase (soon after injury), followed by
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formation and maturation of a granulation tissue, extracellular
matrix remodeling, and new tissue formation (epidermal and
skin appendage regeneration at the end of the observation
period, at day 28, see Figure 1C). In the animals treated with
the cell bioengineered scaffolds, the wound underwent a
faster maturation/remodeling phase, characterized by vascu-
lar progression and increased expression of MMP9 (Figure 3)
in the wound bed 14 days after surgery. Instead, MMP2
expression did not vary in the extracellular matrix of the
animals treated with Integra or Ematrix-MSCs (data not
shown). Of interest, the presence of MSC within the matrices
also greatly ameliorated the quality of the regenerated skin at
day 28 postwounding; indeed, the treatment with MSC-
Integra and in particular with MSC-Ematrix led to a signifi-
cant collagen remodeling, decreased collagen deposition by
Van Gieson staining within the neo-formed tissue
(Figure 1A,C) as compared with the untreated wounds and
those treated with the unseeded matrices, including Ematrix.
Moreover, MSC-seeded matrices induced enhanced
reepithelialization, characterized by a thicker multilayered
epidermis, a greater return of hair follicles and sebaceous
glands (Figure 1B), and enhanced blood vessel formation, as
detected by immunofluorescent staining of CD31, an estab-
lished marker for endothelial cells (Figure 4). By 28 days,
Integra and Ematrix became more difficult to visualize, being
apparently incorporated into the newly formed skin tissues.
Moreover, the transplanted cells were still visible inside the
scaffolds, although in reduced number; these cells were
mainly located within the dermis with some of them migrat-
ing into the epidermal structures, such as the repaired epithe-
lium and sebaceous glands (Figure 5A,B).
To test whether the engrafted MSCs, beside contributing to
the recreation of a suitable microenvironment for wound
repair through paracrine signaling, were able to trans-
differentiate into the skin cell types, the cells were double
immunostained for the expression of GFP and pan-
cytokeratin, a marker of epithelial cell differentiation. The
results showed that none of the engrafted MSCs expressed
pan-cytokeratin 28 days postinjury, suggesting that the trans-
planted cells were unable to differentiate within the cutaneous
wounds, in our experimental conditions (Figure 6A–E). Con-
sistent with this, the engrafted cells displayed a quite imma-
ture phenotype, showing a round-shaped morphology.
Moreover, most of these cells resulted negative for Ki67 a cell
cycle marker, indicating that the wound environment was not
suitable for promoting cell proliferation in the exogenously
delivered MSCs (Figure 6F). Interestingly, GFP–/pan-
cytokeratin+ cells were observed inside the pores of the matri-
ces in the proximity of GFP+-MSCs in the earlier phase of
Figure 1. MSC-seeded matrices improve the quality of regen-
erated skin in rats. Representative light microscopy images of
regenerated skin from each group of animals taken at day 28
postinjury (A,B). Tissues were excised from the wounded
area, fixed in paraformaldehyde or formalin, and stained with
Van Gieson method for collagen (A) or hematoxylin and eosin
(H&E) (B). In the histogram C, the mean collagen content,
epidermal thickness, and hair follicle number in untreated and
treated wounds are reported. Significance of differences
among untreated and treated groups was evaluated by one-
way ANOVA. Values are reported as mean ± SEM. *p < 0.05 vs.
control, #p < 0.05 vs. Integra, °p < 0.05 vs. Integra + MSC.
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wound healing (day 14 after transplantation; Figure 6B–E,G).
These cells were also observed within the transplanted
unseeded matrices but were present in higher amount within
the bioengineered matrices (MSC-Integra and MSC-
Ematrix), providing evidence for a role of MSCs in the
recruitment of epithelial cells at the sites of skin regeneration.
To further clarify the nature of these cells, they were immu-
nostained to detect the cell cycle-associated antigen Ki67.
The findings shown in Figure 6F–H showed that about 40% of
the cells positive for cytokeratin expressed Ki67 within their
nuclei, suggesting that the cells migrating into the matrix
pores represented endogenous epithelial precursors in differ-
ent stages of differentiation, likely recruited by MSCs at these
sites to participate in tissue regeneration.
DISCUSSION
In the present study, we have demonstrated that the use of
bioengineered scaffolds containing MSCs in combination or
not with a mixture of growth factors (MSCs-Integra and
MSCs-Ematrix) greatly ameliorates the quality of cutaneous
repair.
Indeed, the animals receiving MSC-seeded Integra scaffold
showed increased reepithelization and angiogenesis, reduced
dermal collagen content, and a greater return of
skin appendages, as compared with those treated with the
unseeded matrices, including Ematrix. The therapeutic ben-
efits were particularly evident when the wounds were treated
with MSCs seeded on PRP-enriched scaffold, Ematrix, indi-
cating that the incorporation of growth factors within the
pores of the bioengineered scaffolds offered additional thera-
peutic advantages over the presence of MSCs, including the
augmentation of MSC survival and stemness, as also previ-
ously demonstrated.30 One of the possible mechanisms
involved can reside in the presence of a fibrin network, deriv-
ing from platelet activation, that can act as a scaffold to
sequentially deliver different growth factors important in the
process of wound healing.32 We have previously shown18 that
the contribution of MSCs to skin repair/regeneration was due
to their capacity to secrete paracrine signals, such as growth
factors and cytokines, which are relevant for tissue repair/
regeneration.12,13,16,18,30,33 Indeed, we found that the expression
of MMP9, a major factor released by MSCs,31–34 was signifi-
cantly increased in the wound bed of the animals treated with
MSC-seeded matrices. This is an important finding as MMPs
are key regulatory molecules in the remodeling and degrada-
tion of extracellular matrix component. Their up-regulated
expression/activity represents an important event during
Figure 2. MSC-seeded matrices are incorporated into the
cutaneous wounds in rats. Representative confocal images
of wounds after 14 days from the application of the
bioengineered matrices (A,B). Tissues were excised from the
wounded area, fixed in paraformaldehyde, and stained with
antibodies against green fluorescent protein (GFP) recognizing
GFP-MSCs (red) and Syto16 to reveal nuclei (green). The
dermal matrices offer high autofluorescence (arrows). In
the histogram, the mean number of MSCs inside the pores of
the matrices is reported. Significance of differences among
treated groups was evaluated by t test. Values are reported as
mean ± SEM. #p < 0.05.
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Figure 3. MSC-seeded matrices increase MMPs expression.
Representative confocal images of wound healing from each
group of the treated animals taken at day 14 postinjury (A–E).
Tissues were excised from the wounded area, fixed in
paraformaldehyde, and stained with antibodies against MMP9
(green) and GFP to reveal GFP-MSCs (red). Note that MMP9 is
expressed in the ECM, inside the engrafted MSCs and in the
close proximity of the meshes. The dermal matrices are indi-
cated with arrows. The quantitative analysis of MMP9 expres-
sion is reported in the histogram (F). Significance of
differences among untreated and treated groups were evalu-
ated by t test. Values are reported as mean ± SEM. *p < 0.05
vs. control, °p < 0.05 vs. Integra, #p < 0.01 vs. Integra + MSC.
Figure 4. MSC-seeded matrices increase neo-vascularization
of regenerated skin in rats. Representative confocal images of
wounds at day 28 postinjury (A–E). Tissues were excised from
the wounded area, fixed in paraformaldehyde, and stained
with antibodies against CD31, recognizing endothelial cells
(green) and antibodies against GFP, to reveal GFP-MSCs. The
dermal matrices are indicated with arrows. The quantitative
analysis of CD31 positive microvessels (arrowheads) is
reported in the histograms (F). Significance of differences
among untreated and treated groups was evaluated by t test.
Values are reported as mean ± SEM. *p < 0.05 vs. control,
°p < 0.05 vs. Integra, #p < 0.01 vs. Integra + MSC.
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tissue regeneration and skin wound healing,35,36 limiting the
progression of pathological fibrosis and the loss of skin
function.25,26 Moreover, the animals receiving the cell bioen-
gineered matrices showed increased vascularization of the
wound bed, likely due to the release of VEGF and FGF by the
transplanted MSCs. Finally, the paracrine action of MSCs on
wound healing was also supported by data showing that
MSCs, although perfectly integrated with the other connec-
tive tissue cells, retained an undifferentiated morphology and
did not express pan-cytokeratin, an epithelial cell marker,
suggesting to be unable to transdifferentiate into the wound
tissue in our experimental conditions. This result is in contrast
with other reports in the literature showing epidermal differ-
entiation by MSCs. However, most of these studies came
from in vitro experiments, where cells were forced to differ-
entiate in optimized induction media,11,37 which are of unclear
Figure 5. MSCs migration in wounds. Representative confo-
cal images of wound healing from MSCs-Ematrix-treated rats
superimposed on DIC images. Tissues were excised from the
wounded area, fixed in paraformaldehyde, and stained with
antibodies against GFP (A,B) to detect engrafted MSCs at day
28 postinjury. The presence of MSCs within the epidermal
layer and sebaceous glands is indicated with arrows.
Figure 6. MSCs differentiation in wounds. Representative
confocal images of wound healing from each group of the
treated animals. Tissue were excised from wounded area 14
days postinjury and double stained with anti-GFP (red) and
pan-cytokeratin antibodies (green, A–E) to assess epithelial
differentiation. Note that no double-positive cells are identified
to denote cell differentiation by MSCs. The dermal matrices
are indicated with asterisks. Sections were also stained for
GFP (red) and Ki67 (green) expression to reveal cell prolifera-
tion by MSCs (F), and pan-cytokeratin (green) and Ki67 (red), to
detect cell proliferation by the endogenous precursors (G).
Double staining for pan-cytokeratin and Ki67 (arrowheads) in
treated animals with MSC-seeded matrix shows the presence
of replicating epithelial precursors inside the meshes. In F and
G, the confocal images were superimposed to DIC images. In
the histogram (H), the mean number of recruited pan-
cytokeratin+ cells as well as the percentage of Ki67 expressing
cells on the total number of GFP+ cells and the percentage of
Ki67+ on the total number of pan-cytokeratin+ cells in the
treated wounds are reported. Significance of differences
among treated groups was evaluated by t test and one-way
ANOVA. Values are reported as mean ± SEM. °p < 0.01 vs.
control, *p < 0.05 vs. Integra, #p < 0.05 vs. Integra + MSC.
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relevance to the actual differentiation potential in vivo. More-
over, the fact that epithelial transdifferentiation in MSCs is a
limited and rare event in vivo,9,10 given also the small amount
of cells retained soon after the inoculation, questions the real
contribution of this process to the therapeutic benefits
observed following MSC transplantation.
Another important observation of this study was that MSCs,
therapeutically applied to wound, enhanced the recruitment of
the endogenous epithelial precursors to the sites of injury;
GFP-/pan-cytokeratin+ cells were, in fact, found within the
pores of the scaffolds in the close proximity of GFP+-MSCs,
particularly in the animals treated with MSC-Ematrix, suggest-
ing the possibility of a crosstalk between resident epithelial
precursors and the transplanted MSCs in the injured tissue.
Some of the GFP-/pan-cytokeratin+ cells coexpressed Ki67, a
marker of cell cycle, indicating epithelial proliferation. Taking
into consideration our previous in vitro observations showing
that MSCs stimulate proliferation of stem/precursor cells by
paracrine and direct cell contact-mediated interaction,18,30 the
present data expand their biological effects on stem cell func-
tion, suggesting a role for these cells in stimulating migration
of endogenous epidermal precursors at the sites of tissue
repair/regeneration. Indeed, lineage tracing experiments and
functional skin reconstitution studies in mice have unambigu-
ously showed that the interfollicular epidermis38 and the upper
constant region of hair follicles39 contain cells with stem cell
properties. It is, therefore, tempting to speculate that trans-
planted MSCs may favorably imprint the local microenviron-
ment to support the endogenous mechanisms of cutaneous
repair/regeneration. On the other hand, we have also shown, in
the present study, that engrafted MSCs did not proliferate and
their number decreased gradually during the healing progres-
sion, in agreement with previous reports.40 This phenomenon
represents a critical challenge encountered in stem cell therapy,
which may greatly limit their therapeutic efficacy. It is gener-
ally assumed that the loss of engrafted cells is due to the hostile
microenvironment of the cutaneous wound, making it difficult
for the exogenously delivered stem cells to engraft and survive.
Hence, a major focus in this field is to better understand how
stem cells respond to the host environment and to identify
strategies to enhance MSCs survival and maintain their ben-
eficial effects on cutaneous wound repair/regeneration.
In conclusion, the results of this study provide strong evi-
dence that transplantation with MSCs seeded on suitable bio-
logical scaffolds may constitute a promising therapeutic
strategy for the treatment of skin injury. We propose that
MSCs exert a trophic effect on skin wound healing, which
assist and control the host repair/regenerative mechanisms. A
better understanding of the mechanisms mediating the cross-
talk between the injected cells and resident cells may be
relevant for designing therapeutic protocols for skin regenera-
tion after injury and disease and bridge the gap between
preclinical and clinical findings.
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